Global Aurora Kinase A Market Research Report 2024

Report ID: 1970249 | Published Date: Jan 2025 | No. of Page: 94 | Base Year: 2024 | Rating: 4.4 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Aurora Kinase A Market Overview
    1.1 Product Overview and Scope of Aurora Kinase A
    1.2 Aurora Kinase A Segment by Type
        1.2.1 Global Aurora Kinase A Sales Growth Rate Comparison by Type (2022-2028)
        1.2.2 AMG-900
        1.2.3 Danusertib
        1.2.4 ENMD-2076
        1.2.5 Ilorasertib
        1.2.6 Others
    1.3 Aurora Kinase A Segment by Application
        1.3.1 Global Aurora Kinase A Sales Comparison by Application: (2022-2028)
        1.3.2 Ovarian Cancer
        1.3.3 Anaplastic Large Cell Lymphoma
        1.3.4 Brain Tumor
        1.3.5 Others
    1.4 Global Aurora Kinase A Market Size Estimates and Forecasts
        1.4.1 Global Aurora Kinase A Revenue 2017-2028
        1.4.2 Global Aurora Kinase A Sales 2017-2028
        1.4.3 Aurora Kinase A Market Size by Region: 2017 Versus 2021 Versus 2028
2 Aurora Kinase A Market Competition by Manufacturers
    2.1 Global Aurora Kinase A Sales Market Share by Manufacturers (2017-2022)
    2.2 Global Aurora Kinase A Revenue Market Share by Manufacturers (2017-2022)
    2.3 Global Aurora Kinase A Average Price by Manufacturers (2017-2022)
    2.4 Manufacturers Aurora Kinase A Manufacturing Sites, Area Served, Product Type
    2.5 Aurora Kinase A Market Competitive Situation and Trends
        2.5.1 Aurora Kinase A Market Concentration Rate
        2.5.2 The Global Top 5 and Top 10 Largest Aurora Kinase A Players Market Share by Revenue
        2.5.3 Global Aurora Kinase A Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Aurora Kinase A Retrospective Market Scenario by Region
    3.1 Global Aurora Kinase A Retrospective Market Scenario in Sales by Region: 2017-2022
    3.2 Global Aurora Kinase A Retrospective Market Scenario in Revenue by Region: 2017-2022
    3.3 North America Aurora Kinase A Market Facts & Figures by Country
        3.3.1 North America Aurora Kinase A Sales by Country
        3.3.2 North America Aurora Kinase A Revenue by Country
        3.3.3 U.S.
        3.3.4 Canada
    3.4 Europe Aurora Kinase A Market Facts & Figures by Country
        3.4.1 Europe Aurora Kinase A Sales by Country
        3.4.2 Europe Aurora Kinase A Revenue by Country
        3.4.3 Germany
        3.4.4 France
        3.4.5 U.K.
        3.4.6 Italy
        3.4.7 Russia
    3.5 Asia Pacific Aurora Kinase A Market Facts & Figures by Region
        3.5.1 Asia Pacific Aurora Kinase A Sales by Region
        3.5.2 Asia Pacific Aurora Kinase A Revenue by Region
        3.5.3 China
        3.5.4 Japan
        3.5.5 South Korea
        3.5.6 India
        3.5.7 Australia
        3.5.8 Taiwan
        3.5.9 Indonesia
        3.5.10 Thailand
        3.5.11 Malaysia
        3.5.12 Philippines
        3.5.13 Vietnam
    3.6 Latin America Aurora Kinase A Market Facts & Figures by Country
        3.6.1 Latin America Aurora Kinase A Sales by Country
        3.6.2 Latin America Aurora Kinase A Revenue by Country
        3.6.3 Mexico
        3.6.4 Brazil
        3.6.5 Argentina
    3.7 Middle East and Africa Aurora Kinase A Market Facts & Figures by Country
        3.7.1 Middle East and Africa Aurora Kinase A Sales by Country
        3.7.2 Middle East and Africa Aurora Kinase A Revenue by Country
        3.7.3 Turkey
        3.7.4 Saudi Arabia
        3.7.5 UAE
4 Global Aurora Kinase A Historic Market Analysis by Type
    4.1 Global Aurora Kinase A Sales Market Share by Type (2017-2022)
    4.2 Global Aurora Kinase A Revenue Market Share by Type (2017-2022)
    4.3 Global Aurora Kinase A Price by Type (2017-2022)
5 Global Aurora Kinase A Historic Market Analysis by Application
    5.1 Global Aurora Kinase A Sales Market Share by Application (2017-2022)
    5.2 Global Aurora Kinase A Revenue Market Share by Application (2017-2022)
    5.3 Global Aurora Kinase A Price by Application (2017-2022)
6 Key Companies Profiled
    6.1 AbbVie Inc.
        6.1.1 AbbVie Inc. Corporation Information
        6.1.2 AbbVie Inc. Description and Business Overview
        6.1.3 AbbVie Inc. Aurora Kinase A Sales, Revenue and Gross Margin (2017-2022)
        6.1.4 AbbVie Inc. Aurora Kinase A Product Portfolio
        6.1.5 AbbVie Inc. Recent Developments/Updates
    6.2 Amgen Inc.
        6.2.1 Amgen Inc. Corporation Information
        6.2.2 Amgen Inc. Description and Business Overview
        6.2.3 Amgen Inc. Aurora Kinase A Sales, Revenue and Gross Margin (2017-2022)
        6.2.4 Amgen Inc. Aurora Kinase A Product Portfolio
        6.2.5 Amgen Inc. Recent Developments/Updates
    6.3 Astex Pharmaceuticals, Inc.
        6.3.1 Astex Pharmaceuticals, Inc. Corporation Information
        6.3.2 Astex Pharmaceuticals, Inc. Description and Business Overview
        6.3.3 Astex Pharmaceuticals, Inc. Aurora Kinase A Sales, Revenue and Gross Margin (2017-2022)
        6.3.4 Astex Pharmaceuticals, Inc. Aurora Kinase A Product Portfolio
        6.3.5 Astex Pharmaceuticals, Inc. Recent Developments/Updates
    6.4 CASI Pharmaceuticals Inc.
        6.4.1 CASI Pharmaceuticals Inc. Corporation Information
        6.4.2 CASI Pharmaceuticals Inc. Description and Business Overview
        6.4.3 CASI Pharmaceuticals Inc. Aurora Kinase A Sales, Revenue and Gross Margin (2017-2022)
        6.4.4 CASI Pharmaceuticals Inc. Aurora Kinase A Product Portfolio
        6.4.5 CASI Pharmaceuticals Inc. Recent Developments/Updates
    6.5 Merck & Co., Inc.
        6.5.1 Merck & Co., Inc. Corporation Information
        6.5.2 Merck & Co., Inc. Description and Business Overview
        6.5.3 Merck & Co., Inc. Aurora Kinase A Sales, Revenue and Gross Margin (2017-2022)
        6.5.4 Merck & Co., Inc. Aurora Kinase A Product Portfolio
        6.5.5 Merck & Co., Inc. Recent Developments/Updates
    6.6 Millennium Pharmaceuticals, Inc.
        6.6.1 Millennium Pharmaceuticals, Inc. Corporation Information
        6.6.2 Millennium Pharmaceuticals, Inc. Description and Business Overview
        6.6.3 Millennium Pharmaceuticals, Inc. Aurora Kinase A Sales, Revenue and Gross Margin (2017-2022)
        6.6.4 Millennium Pharmaceuticals, Inc. Aurora Kinase A Product Portfolio
        6.6.5 Millennium Pharmaceuticals, Inc. Recent Developments/Updates
    6.7 Sanofi
        6.6.1 Sanofi Corporation Information
        6.6.2 Sanofi Description and Business Overview
        6.6.3 Sanofi Aurora Kinase A Sales, Revenue and Gross Margin (2017-2022)
        6.4.4 Sanofi Aurora Kinase A Product Portfolio
        6.7.5 Sanofi Recent Developments/Updates
    6.8 Sareum Holdings Plc
        6.8.1 Sareum Holdings Plc Corporation Information
        6.8.2 Sareum Holdings Plc Description and Business Overview
        6.8.3 Sareum Holdings Plc Aurora Kinase A Sales, Revenue and Gross Margin (2017-2022)
        6.8.4 Sareum Holdings Plc Aurora Kinase A Product Portfolio
        6.8.5 Sareum Holdings Plc Recent Developments/Updates
    6.9 Sigma-Tau S.p.A.
        6.9.1 Sigma-Tau S.p.A. Corporation Information
        6.9.2 Sigma-Tau S.p.A. Description and Business Overview
        6.9.3 Sigma-Tau S.p.A. Aurora Kinase A Sales, Revenue and Gross Margin (2017-2022)
        6.9.4 Sigma-Tau S.p.A. Aurora Kinase A Product Portfolio
        6.9.5 Sigma-Tau S.p.A. Recent Developments/Updates
    6.10 Taiho Pharmaceutical Co., Ltd.
        6.10.1 Taiho Pharmaceutical Co., Ltd. Corporation Information
        6.10.2 Taiho Pharmaceutical Co., Ltd. Description and Business Overview
        6.10.3 Taiho Pharmaceutical Co., Ltd. Aurora Kinase A Sales, Revenue and Gross Margin (2017-2022)
        6.10.4 Taiho Pharmaceutical Co., Ltd. Aurora Kinase A Product Portfolio
        6.10.5 Taiho Pharmaceutical Co., Ltd. Recent Developments/Updates
    6.11 Vertex Pharmaceuticals Incorporated
        6.11.1 Vertex Pharmaceuticals Incorporated Corporation Information
        6.11.2 Vertex Pharmaceuticals Incorporated Aurora Kinase A Description and Business Overview
        6.11.3 Vertex Pharmaceuticals Incorporated Aurora Kinase A Sales, Revenue and Gross Margin (2017-2022)
        6.11.4 Vertex Pharmaceuticals Incorporated Aurora Kinase A Product Portfolio
        6.11.5 Vertex Pharmaceuticals Incorporated Recent Developments/Updates
    6.12 Vichem Chemie Research Ltd.
        6.12.1 Vichem Chemie Research Ltd. Corporation Information
        6.12.2 Vichem Chemie Research Ltd. Aurora Kinase A Description and Business Overview
        6.12.3 Vichem Chemie Research Ltd. Aurora Kinase A Sales, Revenue and Gross Margin (2017-2022)
        6.12.4 Vichem Chemie Research Ltd. Aurora Kinase A Product Portfolio
        6.12.5 Vichem Chemie Research Ltd. Recent Developments/Updates
7 Aurora Kinase A Manufacturing Cost Analysis
    7.1 Aurora Kinase A Key Raw Materials Analysis
       7.1.1 Key Raw Materials
       7.1.2 Key Suppliers of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
    7.3 Manufacturing Process Analysis of Aurora Kinase A
    7.4 Aurora Kinase A Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
    8.1 Marketing Channel
    8.2 Aurora Kinase A Distributors List
    8.3 Aurora Kinase A Customers
9 Aurora Kinase A Market Dynamics
    9.1 Aurora Kinase A Industry Trends
    9.2 Aurora Kinase A Market Drivers
    9.3 Aurora Kinase A Market Challenges
    9.4 Aurora Kinase A Market Restraints
10 Global Market Forecast
    10.1 Aurora Kinase A Market Estimates and Projections by Type
        10.1.1 Global Forecasted Sales of Aurora Kinase A by Type (2023-2028)
        10.1.2 Global Forecasted Revenue of Aurora Kinase A by Type (2023-2028)
    10.2 Aurora Kinase A Market Estimates and Projections by Application
        10.2.1 Global Forecasted Sales of Aurora Kinase A by Application (2023-2028)
        10.2.2 Global Forecasted Revenue of Aurora Kinase A by Application (2023-2028)
    10.3 Aurora Kinase A Market Estimates and Projections by Region
        10.3.1 Global Forecasted Sales of Aurora Kinase A by Region (2023-2028)
        10.3.2 Global Forecasted Revenue of Aurora Kinase A by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
    12.1 Methodology/Research Approach
        12.1.1 Research Programs/Design
        12.1.2 Market Size Estimation
        12.1.3 Market Breakdown and Data Triangulation
    12.2 Data Source
        12.2.1 Secondary Sources
        12.2.2 Primary Sources
    12.3 Author List
    12.4 Disclaimer

List of Tables
    Table 1. Global Aurora Kinase A Sales Growth Rate Comparison by Type (2022-2028) & (K Pcs) & (US$ Million)
    Table 2. Global Aurora Kinase A Sales Growth Rate Comparison by Application (2022-2028) & (K Pcs) & (US$ Million)
    Table 3. Global Aurora Kinase A Market Size by Region (US$ Million) (2017 VS 2021 VS 2028)
    Table 4. Global Aurora Kinase A Market Competitive Situation by Manufacturers in 2021
    Table 5. Global Aurora Kinase A Sales (K Pcs) of Key Manufacturers (2017-2022)
    Table 6. Global Aurora Kinase A Sales Market Share by Manufacturers (2017-2022)
    Table 7. Global Aurora Kinase A Revenue (US$ Million) by Manufacturers (2017-2022)
    Table 8. Global Aurora Kinase A Revenue Share by Manufacturers (2017-2022)
    Table 9. Global Market Aurora Kinase A Average Price (USD/Pcs) of Key Manufacturers (2017-2022)
    Table 10. Manufacturers Aurora Kinase A Manufacturing Sites and Area Served
    Table 11. Manufacturers Aurora Kinase A Product Type
    Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 13. Global Aurora Kinase A by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Aurora Kinase A as of 2021)
    Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 15. Global Aurora Kinase A Sales by Region (2017-2022) & (K Pcs)
    Table 16. Global Aurora Kinase A Sales Market Share by Region (2017-2022)
    Table 17. Global Aurora Kinase A Revenue by Region (2017-2022) & (US$ Million)
    Table 18. Global Aurora Kinase A Revenue Market Share by Region (2017-2022)
    Table 19. North America Aurora Kinase A Sales by Country (2017-2022) & (K Pcs)
    Table 20. North America Aurora Kinase A Sales Market Share by Country (2017-2022)
    Table 21. North America Aurora Kinase A Revenue by Country (2017-2022) & (US$ Million)
    Table 22. North America Aurora Kinase A Revenue Market Share by Country (2017-2022)
    Table 23. Europe Aurora Kinase A Sales by Country (2017-2022) & (K Pcs)
    Table 24. Europe Aurora Kinase A Sales Market Share by Country (2017-2022)
    Table 25. Europe Aurora Kinase A Revenue by Country (2017-2022) & (US$ Million)
    Table 26. Europe Aurora Kinase A Revenue Market Share by Country (2017-2022)
    Table 27. Asia Pacific Aurora Kinase A Sales by Region (2017-2022) & (K Pcs)
    Table 28. Asia Pacific Aurora Kinase A Sales Market Share by Region (2017-2022)
    Table 29. Asia Pacific Aurora Kinase A Revenue by Region (2017-2022) & (US$ Million)
    Table 30. Asia Pacific Aurora Kinase A Revenue Market Share by Region (2017-2022)
    Table 31. Latin America Aurora Kinase A Sales by Country (2017-2022) & (K Pcs)
    Table 32. Latin America Aurora Kinase A Sales Market Share by Country (2017-2022)
    Table 33. Latin America Aurora Kinase A Revenue by Country (2017-2022) & (US$ Million)
    Table 34. Latin America Aurora Kinase A Revenue Market Share by Country (2017-2022)
    Table 35. Middle East and Africa Aurora Kinase A Sales by Country (2017-2022) & (K Pcs)
    Table 36. Middle East and Africa Aurora Kinase A Sales Market Share by Country (2017-2022)
    Table 37. Middle East and Africa Aurora Kinase A Revenue by Country (2017-2022) & (US$ Million)
    Table 38. Middle East and Africa Aurora Kinase A Revenue Market Share by Country (2017-2022)
    Table 39. Global Aurora Kinase A Sales by Type (2017-2022) & (K Pcs)
    Table 40. Global Aurora Kinase A Sales Market Share by Type (2017-2022)
    Table 41. Global Aurora Kinase A Revenue by Type (2017-2022) & (US$ Million)
    Table 42. Global Aurora Kinase A Revenue Share by Type (2017-2022)
    Table 43. Global Aurora Kinase A Price by Type (2017-2022) & (USD/Pcs)
    Table 44. Global Aurora Kinase A Sales (K Pcs) by Application (2017-2022)
    Table 45. Global Aurora Kinase A Sales Market Share by Application (2017-2022)
    Table 46. Global Aurora Kinase A Revenue by Application (2017-2022) & (US$ Million)
    Table 47. Global Aurora Kinase A Revenue Share by Application (2017-2022)
    Table 48. Global Aurora Kinase A Price by Application (2017-2022) & (USD/Pcs)
    Table 49. AbbVie Inc. Corporation Information
    Table 50. AbbVie Inc. Description and Business Overview
    Table 51. AbbVie Inc. Aurora Kinase A Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 52. AbbVie Inc. Aurora Kinase A Product
    Table 53. AbbVie Inc. Recent Developments/Updates
    Table 54. Amgen Inc. Corporation Information
    Table 55. Amgen Inc. Description and Business Overview
    Table 56. Amgen Inc. Aurora Kinase A Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 57. Amgen Inc. Aurora Kinase A Product
    Table 58. Amgen Inc. Recent Developments/Updates
    Table 59. Astex Pharmaceuticals, Inc. Corporation Information
    Table 60. Astex Pharmaceuticals, Inc. Description and Business Overview
    Table 61. Astex Pharmaceuticals, Inc. Aurora Kinase A Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 62. Astex Pharmaceuticals, Inc. Aurora Kinase A Product
    Table 63. Astex Pharmaceuticals, Inc. Recent Developments/Updates
    Table 64. CASI Pharmaceuticals Inc. Corporation Information
    Table 65. CASI Pharmaceuticals Inc. Description and Business Overview
    Table 66. CASI Pharmaceuticals Inc. Aurora Kinase A Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 67. CASI Pharmaceuticals Inc. Aurora Kinase A Product
    Table 68. CASI Pharmaceuticals Inc. Recent Developments/Updates
    Table 69. Merck & Co., Inc. Corporation Information
    Table 70. Merck & Co., Inc. Description and Business Overview
    Table 71. Merck & Co., Inc. Aurora Kinase A Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 72. Merck & Co., Inc. Aurora Kinase A Product
    Table 73. Merck & Co., Inc. Recent Developments/Updates
    Table 74. Millennium Pharmaceuticals, Inc. Corporation Information
    Table 75. Millennium Pharmaceuticals, Inc. Description and Business Overview
    Table 76. Millennium Pharmaceuticals, Inc. Aurora Kinase A Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 77. Millennium Pharmaceuticals, Inc. Aurora Kinase A Product
    Table 78. Millennium Pharmaceuticals, Inc. Recent Developments/Updates
    Table 79. Sanofi Corporation Information
    Table 80. Sanofi Description and Business Overview
    Table 81. Sanofi Aurora Kinase A Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 82. Sanofi Aurora Kinase A Product
    Table 83. Sanofi Recent Developments/Updates
    Table 84. Sareum Holdings Plc Corporation Information
    Table 85. Sareum Holdings Plc Description and Business Overview
    Table 86. Sareum Holdings Plc Aurora Kinase A Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 87. Sareum Holdings Plc Aurora Kinase A Product
    Table 88. Sareum Holdings Plc Recent Developments/Updates
    Table 89. Sigma-Tau S.p.A. Corporation Information
    Table 90. Sigma-Tau S.p.A. Description and Business Overview
    Table 91. Sigma-Tau S.p.A. Aurora Kinase A Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 92. Sigma-Tau S.p.A. Aurora Kinase A Product
    Table 93. Sigma-Tau S.p.A. Recent Developments/Updates
    Table 94. Taiho Pharmaceutical Co., Ltd. Corporation Information
    Table 95. Taiho Pharmaceutical Co., Ltd. Description and Business Overview
    Table 96. Taiho Pharmaceutical Co., Ltd. Aurora Kinase A Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 97. Taiho Pharmaceutical Co., Ltd. Aurora Kinase A Product
    Table 98. Taiho Pharmaceutical Co., Ltd. Recent Developments/Updates
    Table 99. Vertex Pharmaceuticals Incorporated Corporation Information
    Table 100. Vertex Pharmaceuticals Incorporated Description and Business Overview
    Table 101. Vertex Pharmaceuticals Incorporated Aurora Kinase A Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 102. Vertex Pharmaceuticals Incorporated Aurora Kinase A Product
    Table 103. Vertex Pharmaceuticals Incorporated Recent Developments/Updates
    Table 104. Vichem Chemie Research Ltd. Corporation Information
    Table 105. Vichem Chemie Research Ltd. Description and Business Overview
    Table 106. Vichem Chemie Research Ltd. Aurora Kinase A Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 107. Vichem Chemie Research Ltd. Aurora Kinase A Product
    Table 108. Vichem Chemie Research Ltd. Recent Developments/Updates
    Table 109. Production Base and Market Concentration Rate of Raw Material
    Table 110. Key Suppliers of Raw Materials
    Table 111. Aurora Kinase A Distributors List
    Table 112. Aurora Kinase A Customers List
    Table 113. Aurora Kinase A Market Trends
    Table 114. Aurora Kinase A Market Drivers
    Table 115. Aurora Kinase A Market Challenges
    Table 116. Aurora Kinase A Market Restraints
    Table 117. Global Aurora Kinase A Sales Forecast by Type (2023-2028) & (K Pcs)
    Table 118. Global Aurora Kinase A Sales Market Share Forecast by Type (2023-2028)
    Table 119. Global Aurora Kinase A Revenue Forecast by Type (2023-2028) & (US$ Million)
    Table 120. Global Aurora Kinase A Revenue Market Share Forecast by Type (2023-2028)
    Table 121. Global Aurora Kinase A Sales Forecast by Application (2023-2028) & (K Pcs)
    Table 122. Global Aurora Kinase A Sales Market Share Forecast by Application (2023-2028)
    Table 123. Global Aurora Kinase A Revenue Forecast by Application (2023-2028) & (US$ Million)
    Table 124. Global Aurora Kinase A Revenue Market Share Forecast by Application (2023-2028)
    Table 125. Global Aurora Kinase A Sales Forecast by Region (2023-2028) & (K Pcs)
    Table 126. Global Aurora Kinase A Sales Market Share Forecast by Region (2023-2028)
    Table 127. Global Aurora Kinase A Revenue Forecast by Region (2023-2028) & (US$ Million)
    Table 128. Global Aurora Kinase A Revenue Market Share Forecast by Region (2023-2028)
    Table 129. Research Programs/Design for This Report
    Table 130. Key Data Information from Secondary Sources
    Table 131. Key Data Information from Primary Sources
List of Figures
    Figure 1. Product Picture of Aurora Kinase A
    Figure 2. Global Aurora Kinase A Market Share by Type in 2021 & 2028
    Figure 3. AMG-900 Product Picture
    Figure 4. Danusertib Product Picture
    Figure 5. ENMD-2076 Product Picture
    Figure 6. Ilorasertib Product Picture
    Figure 7. Others Product Picture
    Figure 8. Global Aurora Kinase A Market Share by Application in 2021 & 2028
    Figure 9. Ovarian Cancer
    Figure 10. Anaplastic Large Cell Lymphoma
    Figure 11. Brain Tumor
    Figure 12. Others
    Figure 13. Global Aurora Kinase A Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 14. Global Aurora Kinase A Market Size (2017-2028) & (US$ Million)
    Figure 15. Global Aurora Kinase A Sales (2017-2028) & (K Pcs)
    Figure 16. Aurora Kinase A Sales Share by Manufacturers in 2021
    Figure 17. Global Aurora Kinase A Revenue Share by Manufacturers in 2021
    Figure 18. The Global 5 and 10 Largest Aurora Kinase A Players: Market Share by Revenue in 2021
    Figure 19. Aurora Kinase A Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
    Figure 20. Global Aurora Kinase A Sales Market Share by Region (2017-2022)
    Figure 21. Global Aurora Kinase A Sales Market Share by Region in 2021
    Figure 22. Global Aurora Kinase A Revenue Market Share by Region (2017-2022)
    Figure 23. Global Aurora Kinase A Revenue Market Share by Region in 2021
    Figure 24. U.S. Aurora Kinase A Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 25. Canada Aurora Kinase A Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 26. Germany Aurora Kinase A Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 27. France Aurora Kinase A Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 28. U.K. Aurora Kinase A Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 29. Italy Aurora Kinase A Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 30. Russia Aurora Kinase A Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 31. China Aurora Kinase A Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 32. Japan Aurora Kinase A Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 33. South Korea Aurora Kinase A Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 34. India Aurora Kinase A Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 35. Australia Aurora Kinase A Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 36. Taiwan Aurora Kinase A Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 37. Indonesia Aurora Kinase A Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 38. Thailand Aurora Kinase A Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 39. Malaysia Aurora Kinase A Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 40. Philippines Aurora Kinase A Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 41. Vietnam Aurora Kinase A Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 42. Mexico Aurora Kinase A Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 43. Brazil Aurora Kinase A Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 44. Argentina Aurora Kinase A Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 45. Turkey Aurora Kinase A Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 46. Saudi Arabia Aurora Kinase A Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 47. UAE Aurora Kinase A Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 48. Sales Market Share of Aurora Kinase A by Type (2017-2022)
    Figure 49. Manufacturing Cost Structure of Aurora Kinase A
    Figure 50. Manufacturing Process Analysis of Aurora Kinase A
    Figure 51. Aurora Kinase A Industrial Chain Analysis
    Figure 52. Channels of Distribution
    Figure 53. Distributors Profiles
    Figure 54. Bottom-up and Top-down Approaches for This Report
    Figure 55. Data Triangulation
    Figure 56. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
AbbVie Inc.
Amgen Inc.
Astex Pharmaceuticals, Inc.
CASI Pharmaceuticals Inc.
Merck & Co., Inc.
Millennium Pharmaceuticals, Inc.
Sanofi
Sareum Holdings Plc
Sigma-Tau S.p.A.
Taiho Pharmaceutical Co., Ltd.
Vertex Pharmaceuticals Incorporated
Vichem Chemie Research Ltd.
Frequently Asked Questions
Aurora Kinase A report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Aurora Kinase A report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Aurora Kinase A report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports